Welcome to our dedicated page for HeartSciences news (Ticker: HSCS), a resource for investors and traders seeking the latest updates and insights on HeartSciences stock.
HeartSciences Inc. reports developments as a healthcare information technology company advancing electrocardiography through artificial intelligence. The company’s MyoVista Insights platform is a cloud-native, device-agnostic ECG management system designed for workflow efficiency, EHR interoperability and deployment of cleared AI-ECG algorithms in clinical workflows.
Recurring updates include commercialization of MyoVista Insights, customer and reference-site agreements with hospitals, health networks and academic programs, interoperability milestones such as Epic Toolbox designation, financial results and shareholder meeting matters. HeartSciences also discusses its MyoVista wavECG device, which is designed to provide conventional ECG functionality while supporting on-device AI-enabled solutions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) will have CEO Andrew Simpson present a corporate overview at the Planet MicroCap Showcase: VEGAS 2023, scheduled for April 25-27, 2023, at the Horseshoe Hotel & Casino in Las Vegas.
The presentation is set for April 26, 2023, at 11:00 AM Pacific Time. The event will also allow for one-on-one meetings with Mr. Simpson. HeartSciences focuses on enhancing the diagnostic capacity of Electrocardiograms (ECGs) using AI technology. Their key product candidate, MyoVista®, aims to provide insights into cardiac dysfunction traditionally accessed only through cardiac imaging, aiming to make ECGs a more effective screening tool.
The company leverages a proprietary business model centered around its MyoVista® device, which is expected to generate recurring revenue through consumable electrodes.